Published in PLoS One on February 15, 2017
Molecular basis for cytadsorption of Mycoplasma pneumoniae. J Bacteriol (1982) 5.52
Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature (1996) 5.48
IgE in allergy and asthma today. Nat Rev Immunol (2008) 4.67
Trends in asthma prevalence, health care use, and mortality in the United States, 2001-2010. NCHS Data Brief (2012) 4.00
IgE and mast cells in allergic disease. Nat Med (2012) 3.14
Mast cell-orchestrated immunity to pathogens. Nat Rev Immunol (2010) 3.12
Rhinovirus and respiratory syncytial virus in wheezing children requiring emergency care. IgE and eosinophil analyses. Am J Respir Crit Care Med (1999) 2.76
Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci Transl Med (2015) 2.64
Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma. Am J Respir Crit Care Med (1998) 2.45
Toward primary prevention of asthma. Reviewing the evidence for early-life respiratory viral infections as modifiable risk factors to prevent childhood asthma. Am J Respir Crit Care Med (2015) 2.33
Mycoplasmas: sophisticated, reemerging, and burdened by their notoriety. Emerg Infect Dis (1997) 2.26
A link between chronic asthma and chronic infection. J Allergy Clin Immunol (2001) 2.18
Emergence of macrolide-resistant Mycoplasma pneumoniae with a 23S rRNA gene mutation. Antimicrob Agents Chemother (2005) 2.12
ADP-ribosylating and vacuolating cytotoxin of Mycoplasma pneumoniae represents unique virulence determinant among bacterial pathogens. Proc Natl Acad Sci U S A (2006) 2.00
Immunobiology of asthma. Annu Rev Physiol (2009) 1.97
IgE sensitization to Aspergillus fumigatus is associated with reduced lung function in asthma. Am J Respir Crit Care Med (2010) 1.91
Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin. Chest (2002) 1.84
A beneficial role for immunoglobulin E in host defense against honeybee venom. Immunity (2013) 1.71
Persistence of community-acquired respiratory distress syndrome toxin-producing Mycoplasma pneumoniae in refractory asthma. Chest (2011) 1.64
The role of allergy in severe asthma. Clin Exp Allergy (2012) 1.54
Mast cell secretory granules: armed for battle. Nat Rev Immunol (2014) 1.53
Signal transducer and activator of transcription 6 controls chemokine production and T helper cell type 2 cell trafficking in allergic pulmonary inflammation. J Exp Med (2001) 1.51
Incident asthma and Mycoplasma pneumoniae: A nationwide cohort study. J Allergy Clin Immunol (2015) 1.47
Chlamydophila pneumoniae and Mycoplasma pneumoniae: a role in asthma pathogenesis? Am J Respir Crit Care Med (2005) 1.46
Identification and characterization of human surfactant protein A binding protein of Mycoplasma pneumoniae. Infect Immun (2005) 1.41
Specific IgE against Staphylococcus aureus enterotoxins: an independent risk factor for asthma. J Allergy Clin Immunol (2012) 1.28
Analysis of pulmonary inflammation and function in the mouse and baboon after exposure to Mycoplasma pneumoniae CARDS toxin. PLoS One (2009) 1.27
Chronic rhinosinusitis and asthma: novel understanding of the role of IgE 'above atopy'. J Intern Med (2012) 1.20
Mast cells protect mice from Mycoplasma pneumonia. Am J Respir Crit Care Med (2005) 1.16
Increased risk of pertussis in patients with asthma. J Allergy Clin Immunol (2011) 1.11
Action of pertussigen (pertussis toxin) on serum IgE and on Fc epsilon receptors on lymphocytes. Cell Immunol (1990) 1.10
IL-33-dependent induction of allergic lung inflammation by FcγRIII signaling. J Clin Invest (2013) 1.08
Autoreactive IgE is prevalent in systemic lupus erythematosus and is associated with increased disease activity and nephritis. PLoS One (2014) 1.07
Mycoplasma pneumoniae Community Acquired Respiratory Distress Syndrome toxin expression reveals growth phase and infection-dependent regulation. Mol Microbiol (2010) 1.05
Mast cell activation by Mycobacterium tuberculosis: mediator release and role of CD48. J Immunol (2003) 1.04
Immunoglobulin E receptor signaling and asthma. J Biol Chem (2011) 1.02
Mycoplasma pneumoniae CARDS toxin induces pulmonary eosinophilic and lymphocytic inflammation. Am J Respir Cell Mol Biol (2012) 1.01
Interactions of airway epithelium with protease allergens in the allergic response. Clin Exp Allergy (2010) 0.99
Generation, isolation, and maintenance of rodent mast cells and mast cell lines. Curr Protoc Immunol (2006) 0.99
The cockroach and allergic diseases. Allergy Asthma Immunol Res (2012) 0.98
Cellular vacuoles induced by Mycoplasma pneumoniae CARDS toxin originate from Rab9-associated compartments. PLoS One (2011) 0.96
Enhancement of interleukin-4 production by pertussis toxin. Infect Immun (1993) 0.96
Proteolytic activity of the house dust mite allergen Der p 1 enhances allergenicity in a mouse inhalation model. Clin Exp Allergy (2003) 0.95
Inflammatory response of mast cells during influenza A virus infection is mediated by active infection and RIG-I signaling. J Immunol (2013) 0.94
Understanding the complexity of IgE-related phenotypes from childhood to young adulthood: a Mechanisms of the Development of Allergy (MeDALL) seminar. J Allergy Clin Immunol (2012) 0.93
Community-Acquired Pneumonia Requiring Hospitalization. N Engl J Med (2015) 0.91
Mycoplasma pneumoniae in children with acute and refractory asthma. Ann Allergy Asthma Immunol (2013) 0.90
Immunoglobulin E plays an immunoregulatory role in lupus. J Exp Med (2014) 0.88
Rhinoviruses in the pathogenesis of asthma: the bronchial epithelium as a major disease target. J Allergy Clin Immunol (2006) 0.87
The relationships between atopy, rhinitis and asthma: pathophysiological considerations. Curr Opin Allergy Clin Immunol (2003) 0.85
Mast cells and influenza a virus: association with allergic responses and beyond. Front Immunol (2015) 0.85
Structure of CARDS toxin, a unique ADP-ribosylating and vacuolating cytotoxin from Mycoplasma pneumoniae. Proc Natl Acad Sci U S A (2015) 0.84
Total and specific IgE responses in the acute and recovery phases of respiratory infections in children. J Asthma (1987) 0.84
The relationship between a specific IgE level and asthma outcomes: results from the 2005-2006 National Health and Nutrition Examination Survey. J Allergy Clin Immunol Pract (2013) 0.84
Assessing proxy reports: agreement between children with asthma and their caregivers on quality of life. Ann Allergy Asthma Immunol (2013) 0.83
Functional mapping of community-acquired respiratory distress syndrome (CARDS) toxin of Mycoplasma pneumoniae defines regions with ADP-ribosyltransferase, vacuolating and receptor-binding activities. Mol Microbiol (2014) 0.83
Infection-related asthma. J Allergy Clin Immunol Pract (2014) 0.82
Mast cells protect against airway Mycoplasma pneumoniae under allergic conditions. Clin Exp Allergy (2010) 0.81
Effects of Bordetella pertussis components on IgE and IgG1 responses. Microbiol Immunol (1983) 0.79
Advances in mechanisms of systemic lupus erythematosus. Discov Med (2014) 0.78
New strategies with anti-IgE in allergic diseases. World Allergy Organ J (2014) 0.78
Mycoplasma pneumoniae CARDS toxin exacerbates ovalbumin-induced asthma-like inflammation in BALB/c mice. PLoS One (2014) 0.78
Infection with and Carriage of Mycoplasma pneumoniae in Children. Front Microbiol (2016) 0.78
IgE antibodies, FcεRIα, and IgE-mediated local anaphylaxis can limit snake venom toxicity. J Allergy Clin Immunol (2015) 0.76